DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome
about
Genome-scale screening of drug-target associations relevant to Ki using a chemogenomics approach'RE:fine drugs': an interactive dashboard to access drug repurposing opportunitiesStructure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewImplications of the small number of distinct ligand binding pockets in proteins for drug discovery, evolution and biochemical functionPlumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cellsSystematic drug repositioning based on clinical side-effectsPrediction of chemical-protein interactions network with weighted network-based inference methodPrediction of drug-target interactions for drug repositioning only based on genomic expression similarityTowards structural systems pharmacology to study complex diseases and personalized medicineConstruction of drug network based on side effects and its application for drug repositioningDrug repositioning for diabetes based on 'omics' data miningHypothyroidism Side Effect in Patients Treated with Sunitinib or Sorafenib: Clinical and Structural AnalysesDrug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data MiningNetwork-based in silico drug efficacy screeningDPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein InteractomeIn Silico target fishing: addressing a "Big Data" problem by ligand-based similarity rankings with data fusion.Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity dataDDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome.Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study.Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs)A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models.ProBiS-2012: web server and web services for detection of structurally similar binding sites in proteins.Comprehensive prediction of drug-protein interactions and side effects for the human proteome.Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse EventsDiscovery of the molecular mechanisms of the novel chalcone-based Magnaporthe oryzae inhibitor C1 using transcriptomic profiling and co-expression network analysis.Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.Network-based drug repositioning.Contributions from emerging transcriptomics technologies and computational strategies for drug discovery.Targeting molecular networks for drug researchPolypharmacology in Drug Development: A Minireview of Current Technologies.Using reverse docking for target identification and its applications for drug discovery.Toxicological Differences Between NMDA Receptor Antagonists and Cholinesterase Inhibitors.SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning.Towards drug repositioning: a unified computational framework for integrating multiple aspects of drug similarity and disease similarity.Targets of drugs are generally, and targets of drugs having side effects are specifically good spreaders of human interactome perturbationsIdentification of a Potential Target of Capsaicin by Computational Target Fishing.System Pharmacology-Based Dissection of the Synergistic Mechanism of Huangqi and Huanglian for Diabetes Mellitus.Potential antitumor mechanisms of phenothiazine drugs.
P2860
Q21133651-3C632E12-DEEC-486A-B1D9-2A99592D2665Q24745976-A8999981-77A0-4EB0-A913-741A6CF8BEEFQ27008867-9A5C6BF0-2D2D-43EF-B86F-6B1B222DF208Q27026364-BFA65CDC-FBB0-43CF-BC43-B6FA6FB81F1AQ28385880-DD1851F6-6CF4-4A4D-B9DE-E461EFB5848BQ28478506-0F1D25AA-1609-4334-B8F0-EB204C0F12A8Q28481329-91538D32-6B1B-4EE3-9747-7E79BE9C6503Q28534907-5BD57396-A0BB-43E3-9452-C6E578474550Q28538838-C588237C-B133-4678-9749-CC8AEA7D3FC2Q28539501-992BE161-C7D9-45A0-9598-8E96E11DB598Q28547042-CB7D85F3-91FA-46AF-BADD-38DEF14D72C2Q28552577-CA64F3F4-DBA0-4676-BA17-1EA78D761264Q28555197-0AEE46B8-9627-439F-BC62-8E09B6990DFEQ28601372-234001F6-9EDA-4422-9D09-D7DC00428BB7Q28822352-03CAB1EB-6DE7-4001-B30D-BFCD635C51FEQ30833986-76C3FDF1-3138-42D0-9D24-A553365EC8E2Q31138564-9D67BA2C-1827-4D01-B39A-AB098280A5CFQ31172453-9D5184D5-D1C6-4AD6-B6B7-7D5984617AEAQ33860716-C1A40F28-0209-46CB-8186-61B067581C60Q34742606-25D83636-D254-48D3-AFEF-E8D29A4CE755Q35006731-A348B379-3711-4E76-8C19-8223DFAECFD6Q35928666-AFD93F24-5414-4A83-BD9F-C7B5BC129A6AQ36014246-55538EAD-2B65-4F80-8332-78DF2054D1B8Q36088530-54B55C9D-0266-4146-BFD3-5E304BC901DFQ36156312-E4B25448-5277-44C0-AB86-7B26CFA49996Q36804419-A1131780-B940-44F2-BB51-CEF519E18B68Q37359148-7FFB80D3-DB97-4947-BDA0-0CDA65885125Q37696080-CB8E9B24-C3DE-41A5-84F1-DAAD0E6C95F6Q38089597-5C8CBA75-E797-42AC-8134-B6EACDDCC73BQ38196339-2C422C8B-0665-41E3-9707-C0F2C31D4E9BQ38219973-83857B42-AE3A-4C0A-9C1D-794D10958AB6Q38827815-78774615-FEAB-4F4B-9186-44CA2E4B8B8FQ38836168-A607FDED-7290-42A2-B41A-1DFB0E61014CQ38920515-D62A63C2-9278-4AAB-983F-6DC5850DCB26Q39947451-E2D799AD-43C6-4000-964A-11AB1AD62FABQ40272650-80749305-6D80-4ED1-ABA3-3427D0CF67BEQ40513256-33606229-CD50-4D4E-8A65-2C5D34605CBBQ41952821-565DC135-AC0C-41B8-BC46-255B51DAB5A4Q42373475-0B027489-5931-4ADF-A9DB-C1872C262E69Q43795724-9BAC716D-0C92-4DAE-BF36-8F0E03BD118C
P2860
DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
DRAR-CPI: a server for identif ...... e chemical-protein interactome
@ast
DRAR-CPI: a server for identif ...... e chemical-protein interactome
@en
type
label
DRAR-CPI: a server for identif ...... e chemical-protein interactome
@ast
DRAR-CPI: a server for identif ...... e chemical-protein interactome
@en
prefLabel
DRAR-CPI: a server for identif ...... e chemical-protein interactome
@ast
DRAR-CPI: a server for identif ...... e chemical-protein interactome
@en
P2093
P2860
P356
P1476
DRAR-CPI: a server for identif ...... e chemical-protein interactome
@en
P2093
Kejian Wang
Leming Shi
Mike Mikailov
P2860
P304
P356
10.1093/NAR/GKR299
P407
P433
Web Server issue
P577
2011-05-10T00:00:00Z